NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-259-1998-2-US-09 Variants of Humanized Anti-Carcinoma MAB CC49 US DIV 12/819,920 8029788 Expired PDF
NCI E-204-2010-0-US-01 Methods of Treating Neuroblastoma US 61/356,202 Abandoned
NCI E-170-2010-0-US-01 Linked Purine Pterin HPPK Inbibitors Useful As Antibacterial Agents US 61/356,213 Abandoned
NCI E-201-2010-0-US-01 Immunogenic Compositions Derived from Structural Alteration of Hiv Envelope Proteins US 61/356,326 Abandoned
NCI E-183-2010-0-US-01 Compositions and Methods for Treating Inflammatory Conditions US 61/355,965 Abandoned
NCI E-059-2009-0-PCT-02 RNA Nanoparticles and Methods of Use PCT PCT PCT/US2010/038818 Expired
NIDDK E-064-2004-0-JP-15 The Use Of Leptin For Treating Human Lipoatrophy JP DIV 2010-137501 Expired
NCI E-158-2010-0-US-01 Agonistic Human Monoclonal Antibody Against DR4 US 61/355,349 Abandoned
NICHD E-023-2002-0-US-03 BACILLUS ANTHRACIS PROTECTIVE ANTIGEN NUCLEIC ACID SEQUENCES US DIV 12/816,285 8044189 Expired PDF
NCI E-071-2009-0-US-03 METHODS TO DIAGNOSE AND IMMUNIZE AGAINST THE VIRUS CAUSING HUMAN MERKEL CELL CARCINOMA US National Stage 12/808,042 8524248 Issued PDF
NCI E-011-1998-0-US-06 Mammalian Selenoprotein Differentially Expressed in Tumor Cells US DIV 12/814,933 Abandoned
NIAMS E-286-2010-0-US-02 IN VITRO BONE MODEL AND DISTRACTION DEVICE US ORD 61/354,625 Abandoned
NIAMS E-286-2010-0-GB-01 IN VITRO BONE MODEL AND DISTRACTION DEVICE GB ORD 1009939.8 Abandoned
NIDCR E-300-2008-0-PCT-02 Identification Of DSG3 As A Biomarker For The Detection Of Occult Metastasis In Sentinel Lymph Nodes PCT PCT PCT/US2010/038325 Expired
NCI E-286-2007-0-US-02 Methods for Increasing Levels of Fetal Hemoglobin US National Stage 12/523,565 Abandoned
NIAID E-133-2011-0-JP-06 Vaccines Directed Against Adenovirus Serotype 14 JP National Stage 2010-538163 Abandoned
NICHD E-247-2009-2-IN-07 DENDRIMER BASED NANODEVICES IN National Stage 406/CHENP/2012 Abandoned
NICHD E-247-2009-2-IE-16 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes IE EP 10789963.5 Abandoned
NICHD E-247-2009-2-AT-11 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes AT EP 10789963.5 Abandoned
NICHD E-247-2009-2-CH-12 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes CH EP 10789963.5 Abandoned
NICHD E-247-2009-2-FR-14 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes FR EP 10789963.5 Abandoned
NICHD E-247-2009-2-DE-13 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes DE EP 10789963.5 Abandoned
NICHD E-247-2009-2-GB-15 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes GB EP 10789963.5 Abandoned
NICHD E-247-2009-2-EP-03 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes EP National Stage 10789963.5 Abandoned
NICHD E-247-2009-2-AU-05 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes AU National Stage 2010260349 Abandoned
NICHD E-247-2009-2-US-02 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes US ORD 12/797,657 8889101 Issued PDF
NCI E-281-2007-1-US-01 Methods of Monitoring Angiogenesis and Metastasis in Three Dimensional Co-Cultures US CIP 12/802,666 8679836 Issued PDF
NICHD E-247-2009-2-PCT-01 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes PCT PCT COMB PCT/US2010/038068 Expired
NIDA E-027-2010-0-US-02 Method of Protecting Against Stroke Through the Use of a Delta Opioid Peptide US National Stage 12/813,191 Abandoned
NIDDK E-177-2010-0-US-01 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents US 61/353,274 Abandoned
NICHD E-247-2009-2-IL-06 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes IL National Stage 217035 Abandoned
NICHD E-247-2009-2-CA-04 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes CA National Stage 2767163 Abandoned
NCI E-044-2003-0-US-06 Compositions Comprising Nucleic Acids Encoding HIV-1 Reverse Transcriptase CTL Epitopes US CON 12/796,614 8877914 Abandoned PDF
NIDDK E-064-2004-0-BG-30 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment BG EP 10165256.8 Expired
NIDDK E-064-2004-0-CZ-33 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment CZ EP 10165256.8 Expired
NIDDK E-064-2004-0-CY-32 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment CY EP 10165256.8 Expired
NIDDK E-064-2004-0-IT-43 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment IT EP 10165256.8 Expired
NIDDK E-064-2004-0-IE-42 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment IE EP 10165256.8 Expired
NIDDK E-064-2004-0-GR-41 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment GR EP 10165256.8 Expired
NIDDK E-064-2004-0-AT-28 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment AT EP 10165256.8 Expired
NIDDK E-064-2004-0-BE-29 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment BE EP 10165256.8 Expired
NIDDK E-064-2004-0-AL-27 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment AL EP 10165256.8 Expired
NIDDK E-064-2004-0-LU-46 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LU EP 10165256.8 Expired
NIDDK E-064-2004-0-LT-45 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LT EP 10165256.8 Expired
NIDDK E-064-2004-0-LI-44 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LI EP 10165256.8 Expired
NIDDK E-064-2004-0-LV-47 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LV EP 10165256.8 Expired
NIDDK E-064-2004-0-EE-36 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment EE EP 10165256.8 Expired
NIDDK E-064-2004-0-DE-34 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment DE EP 10165256.8 Expired
NIDDK E-064-2004-0-DK-35 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment DK EP 10165256.8 Expired
NIDDK E-064-2004-0-FI-38 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment FI EP 10165256.8 Expired